Assured Investment Management’s Pacira BioSciences PCRX Stock Holding History

Assured Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-18,664	Closed	-$710K	–	616
2019 Q1	$710K	Buy	18,664 +5,463	+41%	+$213K	0.01%	470
2018 Q4	$568K	Buy	13,201 +10,754	+439%	+$502K	0.02%	618
2018 Q3	$120K	Sell	2,447 -7,419	-75%	-$321K	﹤0.01%	1019
2018 Q2	$316K	Buy	9,866 +7,284	+282%	+$251K	0.01%	930
2018 Q1	$80K	Buy	+2,582	New	+$91.9K	﹤0.01%	1067
2015 Q3	–	Sell	-1,725	Closed	-$122K	–	692
2015 Q2	$122K	Buy	+1,725	New	+$136K	﹤0.01%	552

Other funds holding PCRX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Assured Investment Management's PCRX Position: Q2 2019 in Review

Assured Investment Management sold out of Pacira BioSciences (PCRX) in Q2 2019, closing a stake of 18,664 shares — an estimated $710K sold.

Assured Investment Management first reported a position in PCRX in Q2 2015 and held it in 6 quarters. The position peaked at $710K in Q1 2019. 218 funds tracked by Wall St. Rank hold PCRX as of Q2 2019.

Assured Investment Management reported no remaining Pacira BioSciences position as of Q2 2019 after selling out during the quarter.
Assured Investment Management sold 18,664 Pacira BioSciences shares in Q2 2019, an estimated $710K.
Assured Investment Management first reported a position in Pacira BioSciences in Q2 2015 and held it in 6 quarters.
Assured Investment Management's Pacira BioSciences position peaked at $710K in Q1 2019.
218 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.